Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alveolar macrophage dysfunction in malignant lung tumours.

E Lemarie, P Carre, M F Legrand

    Thorax
    |June 1, 1984
    PubMed
    Summary

    Alveolar macrophage chemotaxis is reduced in patients with bronchial carcinoma, suggesting a potential functional defect that may promote lung cancer development. Recent infections temporarily boost chemotaxis in healthy individuals but not in tumor-bearing patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Lack of essential medical resources leaves Africa breathless.

    The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
    Same author

    Fate of inhaled monoclonal antibodies after the deposition of aerosolized particles in the respiratory system.

    Journal of controlled release : official journal of the Controlled Release Society·2014
    Same author

    Brain neocortex and the immune system.

    Immunology today·2014
    Same author

    [Individual lung cancer screening in practice. Perspectives on the propositions from the multidisciplinary group of the Intergroupe francophone de cancérologie thoracique, the Société d'imagerie thoracique and the Groupe d'oncologie de langue française].

    Revue des maladies respiratoires·2014
    Same author

    Can exhaled nitric oxide differentiate causes of pulmonary fibrosis?

    Respiratory medicine·2013
    Same author

    [From the NLST randomized trial to the clinic: how should we implement individual lung cancer screening in clinical practice?].

    Revue des maladies respiratoires·2013

    Area of Science:

    • Immunology
    • Pulmonology
    • Oncology

    Background:

    • Alveolar macrophages play a crucial role in lung immunity and host defense.
    • Altered macrophage function is implicated in various pulmonary diseases, including cancer.

    Purpose of the Study:

    • To investigate alveolar macrophage chemotaxis in patients with different pulmonary conditions, including lung cancer.
    • To determine if impaired chemotaxis is associated with the development of primary bronchial carcinoma.

    Main Methods:

    • Chemotaxis assay of alveolar macrophages from 129 individuals (healthy volunteers, patients with infections, chronic bronchitis, sarcoidosis, lung cancer, and metastases).
    • Stimulation of chemotaxis using zymosan-activated autologous serum, N-formyl-methionine-leucyl-phenylalanine (F-Met-Leu-Phe), or activated human AB serum.

    Related Experiment Videos

    Main Results:

    • Significantly reduced alveolar macrophage chemotaxis in patients with primary bronchial carcinoma compared to healthy volunteers.
    • Chemotaxis was more depressed near the tumor site than in the contralateral lung.
    • Defective chemotaxis was also observed in sarcoidosis patients; lung metastases did not impact chemotaxis.
    • Recent bronchopulmonary infections increased chemotaxis in tumor-free patients, but not in those with primary lung tumors.

    Conclusions:

    • An intrinsic functional defect in alveolar macrophages may predispose individuals to developing bronchogenic carcinoma.
    • Alveolar macrophage dysfunction is a potential factor in lung cancer pathogenesis.